Castle Biosciences, Inc.

NASDAQ:CSTL

30.53 (USD) • At close September 19, 2024
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q1
Omzet 87.00272.97466.1261.49350.13842.03738.33837.01134.83826.85225.03923.47522.75822.81317.29915.21712.71517.41817.63514.77510.7398.71711.4363.7123.9793.659
Kosten van de omzet 17.2316.57915.09411.31911.05810.1829.528.8597.6865.9444.5974.53.6973.0282.6732.4752.1462.3912.0111.7091.9931.5981.3661.3511.3271.253
Brutowinst 69.77256.39551.02650.17439.0831.85528.81828.15227.15220.90820.44218.97519.06119.78514.62612.74210.56915.02715.62413.0668.7467.11910.072.3612.6532.406
Brutowinstmarge 0.8020.7730.7720.8160.7790.7580.7520.7610.7790.7790.8160.8080.8380.8670.8450.8370.8310.8630.8860.8840.8140.8170.8810.6360.6670.658
Onderzoek- en ontwikkelingskosten 14.05113.45512.9112.92313.30814.39311.30910.90711.92610.7619.4457.56.7935.9084.5813.0582.7042.9133.1591.5151.3171.3941.1381.2941.1591.263
Algemene en administratieve kosten 18.41317.95117.12616.12316.42916.81730.15514.23815.9170000014.95911.70310.39211.0789.8527.1226.8216.04703.9184.164.228
Verkoop- en marketingkosten 32.67530.54426.96428.49628.25229.945-43.96922.38821.581000000000-00000000
Verkoop-, algemene en administratieve kosten 50.70948.41143.77444.61944.68146.76238.42636.62637.49830.45325.1622.59520.82218.16114.95911.70310.39211.0789.8527.1226.8216.0474.1643.9184.164.228
Overige kosten 2.2472.2472.2712.2722.2482.2222.2152.3062.0974.215.6050.6940.25600000-0-2.71-0.19-0.033-0.243-0.0430.034-0.021
Bedrijfskosten 64.7661.86656.68459.81460.23763.37751.9549.83951.52145.42435.61330.78927.87124.06917.65816.64311.21413.99113.0118.6378.1387.445.3025.2135.3195.49
Bedrijfsresultaat 5.012-5.471-5.658-9.64-21.157-31.522-23.132-21.687-24.369-24.516-15.171-11.814-8.81-4.284-3.032-3.901-0.6451.0362.6134.4290.608-0.3214.767-2.852-2.666-3.085
Bedrijfsresultaat ratio 0.058-0.075-0.086-0.157-0.422-0.75-0.603-0.586-0.699-0.913-0.606-0.503-0.387-0.188-0.175-0.256-0.0510.0590.1480.30.057-0.0370.417-0.768-0.67-0.843
Totaal overige inkomsten en kosten netto 2.8742.9823.1172.7672.3962.3322.5711.43820.7640.0270.0010.0230.0240.004-1.397-0.688-0.731-0.466-02.503-0.19-0.033-0.243-0.0430.034-0.021
Inkomen voor belasting 7.886-2.489-2.541-6.873-18.761-29.19-20.561-20.249-3.605-24.489-15.155-11.791-8.786-4.28-4.805-4.589-1.3760.572.1275.849-1.269-1.3583.877-3.45-3.155-3.63
Inkomen voor belasting ratio 0.091-0.034-0.038-0.112-0.374-0.694-0.536-0.547-0.103-0.912-0.605-0.502-0.386-0.188-0.278-0.302-0.1080.0330.1210.396-0.118-0.1560.339-0.929-0.793-0.992
Belastingkosten -1.0340.0450.0390.0320.0160.0140.057-1.438-1.9570.134-8.7250.0230.0050.0040.0840.0180.0380.2980.072306.469995.6670.9910.0090.5260.5590.51
Nettowinst 8.92-2.534-2.58-6.905-18.777-29.204-20.618-18.811-1.648-24.623-6.43-11.791-8.791-4.28-4.889-4.589-1.3760.572.0555.849-1.269-1.3583.868-3.45-3.155-3.63
Nettowinstmarge 0.103-0.035-0.039-0.112-0.375-0.695-0.538-0.508-0.047-0.917-0.257-0.502-0.386-0.188-0.283-0.302-0.1080.0330.1170.396-0.118-0.1560.338-0.929-0.793-0.992
WPA (Winst Per Aandeel) 0.32-0.092-0.095-0.26-0.7-1.1-0.78-0.72-0.063-0.97-0.25-0.47-0.35-0.17-0.24-0.23-0.080.030.120.43-0.082-0.130.36-0.32-0.3-0.34
Verwaterde WPA 0.31-0.092-0.095-0.26-0.7-1.1-0.78-0.71-0.063-0.97-0.25-0.47-0.35-0.17-0.23-0.23-0.0780.030.110.05-0.082-0.130.36-0.32-0.3-0.34
EBITDA 8.36-2.131-2.434-3.697-15.718-26.294-18.642-17.471-21.371-22.335-14.146-10.702-8.152-4.047-3.013-3.764-0.5051.4252.8931.8150.424-0.2544.607-2.798-2.55-3.02
EBITDA ratio 0.096-0.029-0.037-0.06-0.313-0.625-0.486-0.472-0.613-0.832-0.565-0.456-0.358-0.177-0.174-0.247-0.040.0820.1640.1230.039-0.0290.403-0.754-0.641-0.826